Mid-sized pharma company Glenmark Pharmaceuticals has decided to set up a facility to produce oncology drugs in Buenos Aires in Argentina to strengthen its presence in the global cancer drug market that is expected to grow by nearly 80% to $85 billion in four years.

Lupin and Glenmark Pharmaceuticals are leading Indian mid-cap drug makers in exploiting rising demand for medicines in South American nations, such as Brazil and Argentina, even as competition and rules intensify in the developed markets of the US and Europe.

Brand ambassador Kajol Devgan promotes the kiss of good health. Expanding its footprint in India, Yakult Danone India (P) Ltd. announced its expansion by launching Yakult, a global probiotic health drink in the city today.

Bangalore-based life sciences company AVESTHAGEN has revived plans for an IPO and the company will raise approximately Rs 600-700 crores from the domestic and international markets.